[Antibody therapeutics: an American view of an amazing present and future]

Med Sci (Paris). 2019 Dec;35(12):924-925. doi: 10.1051/medsci/2019244. Epub 2020 Jan 6.

[Article in French]

Author

Janice M Reichert¹

Affiliation

¹ Ph.D, Editor-in-Chief, mAbs, Executive Director, The Antibody Society, Framingham, MA, États-Unis.

PMID: 31903895
DOI: 10.1051/medsci/2019244

No abstract available

Publication types

Editorial
Historical Article

MeSH terms

Antibodies, Monoclonal / history
Antibodies, Monoclonal / therapeutic use*
Biomedical Research / history
Biomedical Research / methods
Biomedical Research / trends
Biosimilar Pharmaceuticals / classification
Biosimilar Pharmaceuticals / standards
Biosimilar Pharmaceuticals / therapeutic use
France
History, 20th Century
History, 21st Century
Humans
Immunotherapy / history
Immunotherapy / methods
Immunotherapy / trends
Therapeutics / history
Therapeutics / methods
Therapeutics / trends*
United States

Substances

Antibodies, Monoclonal
Biosimilar Pharmaceuticals